NL-OMON25820已完成不适用
ow dose vitamin K to improve therapeutic quality control of oral anticoagulant treatment: a randomized double-blind placebo controlled trial.
Trombosestichting Nederland0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
J Thromb Haemost. 2007 Oct;5(10):2043-8. Epub 2007 Jul 31.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients treated at the Leiden anticoagulation clinic with an indication for long-term oral anticoagulant therapy using the vitamin K antagonist phenprocoumon;
- •2. Age between 18 and 80 years;
排除标准
- •1. Treatment by a medical specialist for liver failure;
- •2. Haemo- or peritoneal dialysis;
研究者
相似试验
已完成
不适用
ow dose vitamin K to improve therapeutic quality control of oral anticoagulant treatment: a randomised double-blind placebo controlled trialThrombosis, emboly, anticoagulant treatmentHaematological DisordersAnticoagulant treatmentISRCTN14473912eiden University Medical Center (LUMC) (The Netherlands)200
Unknown
4 期
Comparison of Vitamin K Doses in Patients With Larger Burn InjuriesBurnsNCT03941535Joseph M. Still Research Foundation, Inc.50
已完成
不适用
Vitamin K to improve markers of vascular health and physical function in older people with vascular diseaseISRCTN93213492Tayside Academic Sciences Collaboration (UK)80
已完成
不适用
Vitamin K therapy to improve vascular health in patients with chronic kidney diseaseChronic kidney disease stages 3b and 4Urological and Genital DiseasesISRCTN21444964Tayside Academic Science Centre (NHS Tayside and University of Dundee)159
已完成
3 期
Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin TherapyCoagulationNCT00794755Ottawa Hospital Research Institute100